Recombinant HIV-1 Protease

• Description:

  Recombinant HIV-1 Protease_x000D_ Catalog number: B2011380_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 5 µg_x000D_ Molecular Weight or Concentration: 0.2 mg/mL_x000D_ Supplied as: Solution_x000D_ Applications: molecular tool for various biochemical applications_x000D_ Storage: -80 °C_x000D_ Keywords: HIV-1 protease, recombinant_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Eche S, Gordon ML. Recombinant expression of HIV-1 protease using soluble fusion tags in Escherichia coli: A vital tool for functional characterization of HIV-1 protease Virus Res. 2021 Apr 2;295:198289._x000D_ 2: Azarnezhad A, Sharifi Z, Seyedabadi R, Hosseini A, Johari B, Sobhani Fard M. Cloning and Expression of Soluble Recombinant HIV-1 CRF35 Protease-HP Thioredoxin Fusion Protein Avicenna J Med Biotechnol. 2016 Oct-Dec;8(4):175-181._x000D_ 3: Maseko SB, Govender D, Govender T, Naicker T, Lin J, Maguire GEM, Kruger HG. Optimized Procedure for Recovering HIV-1 Protease (C-SA) from Inclusion Bodies Protein J. 2019 Feb;38(1):30-36._x000D_ 4: Miczi M, Diós Á, Bozóki B, TÅ‘zsér J, Mótyán JA. Development of a Bio-Layer Interferometry-Based Protease Assay Using HIV-1 Protease as a Model Viruses. 2021 Jun 21;13(6):1183._x000D_ 5: Mótyán JA, Miczi M, Oroszlan S, TÅ‘zsér J. Specificity of the HIV-1 Protease on Substrates Representing the Cleavage Site in the Proximal Zinc-Finger of HIV-1 Nucleocapsid Protein Viruses. 2021 Jun 8;13(6):1092._x000D_ 6: Eche S, Kumar A, Sonela N, Gordon ML. Acquired HIV-1 Protease Conformational Flexibility Associated with Lopinavir Failure May Shape the Outcome of Darunavir Therapy after Antiretroviral Therapy Switch Biomolecules. 2021 Mar 24;11(4):489._x000D_ 7: Saladini F, Giannini A, Boccuto A, Vicenti I, Zazzi M. Agreement between an in-house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to HIV-1 protease, reverse transcriptase, and integrase inhibitors J Clin Lab Anal. 2018 Jan;32(1):e22206._x000D_ 8: El Moussi A, Thomson MM, Delgado E, Cuevas MT, Nasr M, Abid S, Ben Hadj Kacem MA, Benaissa Tiouiri H, Letaief A, Chakroun M, Ben Jemaa M, Hamdouni H, Tej Dellagi R, Kheireddine K, Boutiba I, Pérez-Álvarez L, Slim A. Genetic Diversity of HIV-1 in Tunisia AIDS Res Hum Retroviruses. 2017 Jan;33(1):77-81._x000D_ 9: Puertas MC, Buzón MJ, Ballestero M, Van Den Eede P, Clotet B, Prado JG, Martinez-Picado J. Novel two-round phenotypic assay for protease inhibitor susceptibility testing of recombinant and primary HIV-1 isolates J Clin Microbiol. 2012 Dec;50(12):3909-16._x000D_ 10: Volontè F, Piubelli L, Pollegioni L. Optimizing HIV-1 protease production in Escherichia coli as fusion protein Microb Cell Fact. 2011 Jun 30;10:53. _x000D_ _x000D_ Products Related to Recombinant HIV-1 Protease can be found at Proteins

• Short Description:

  Catalog Number: B2011380 (5 µg)_x000D_ Recombinant HIV-1 Protease is a high quality recombinant HIV-1 protease. This product has been used as molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request._x000D_ _x000D_

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height :

  0.5

• CAS Number:

  9000-83-3